1: To adopt the Agreement and Plan of Merger among Amicus Therepeutics and BioMarin Pharmaceutical – For (196.491)
2: To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus’ named executive officers that is based on or otherwise relates to the Merger. – For (196.491)
3: To approve the adjournment of the special meeting if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting. – For (196.491)
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.